Ubs Group Ag Glaukos Corp Transaction History
Ubs Group Ag
- $397 Billion
- Q1 2024
A detailed history of Ubs Group Ag transactions in Glaukos Corp stock. As of the latest transaction made, Ubs Group Ag holds 37,682 shares of GKOS stock, worth $4.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,682
Previous 37,115
1.53%
Holding current value
$4.5 Million
Previous $2.95 Million
20.44%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding GKOS
# of Institutions
273Shares Held
43.6MCall Options Held
89.8KPut Options Held
236K-
Black Rock Inc. New York, NY7.9MShares$942 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.31MShares$633 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.13MShares$254 Million3.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$218 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.61MShares$192 Million0.09% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $5.68B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...